Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.39 |
| ▸ | DRD3 | P35462 | 4/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21274471 | 0.86 | SMO (0.42) | DRD2DRD3PARP1ADRA1AADRA1D | |
| SCHEMBL21281581 | 0.85 | PARP1 (0.38) | DRD2DRD3PARP1ADRA1AKMT2A | |
| SCHEMBL21274107 | 0.84 | OPRM1 (0.45) | DRD2DRD3PARP1ADRA1AKMT2A | |
| SCHEMBL21274394 | 0.82 | NPC1 (0.37) | DRD2DRD3PARP1ADRA1AADRA1D | |
| SCHEMBL21281500 | 0.81 | ADRA1A (0.45) | DRD2DRD3PARP1ADRA1AADRA1D | |
| SCHEMBL21273954 | 0.80 | PARP1 (0.45) | DRD2DRD3PARP1ADRA1AADRA1D | |
| SCHEMBL21268787 | 0.79 | PARP1 (0.42) | DRD2DRD3PARP1ADRA1AKMT2A | |
| SCHEMBL21285605 | 0.78 | ADRA1B (0.38) | DRD2DRD3PARP1ADRA1AADRA1D | |
| SCHEMBL21274036 | 0.78 | NPC1 (0.35) | PARP1ADRA1AKMT2AADRA1DADRA1B | |
| SCHEMBL21285495 | 0.77 | PARP1 (0.42) | DRD2DRD3PARP1ADRA1AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527209-A1 | PHARMACEUTICAL 6,5 HETEROBICYCLIC RING DERIVATIVES | UCB Biopharma SPRL (BE) | 2019-08-21 | — | — | EP | disclosed |